(NU/1433- 41) IngeniumAI: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Tender description

At IngeniumAI we aim to address the unnecessary delays in disease diagnosis. Currently the diagnosis of many diseases takes far too long. For example, to receive a diagnosis the average pulmonary hypertension (PH) patient has 5.3 GP visits and 3 referrals, taking on average 2 years, 2 months. By this point treatment options are severely limited. If left untreated the average time to mortality is only 2 years, 6 months. Delays in diagnosis of PH are estimated to cost more than £27,000 per patient in additional healthcare resources and more than £100,000 in wider economic costs. The total UK cost is more than £250m per year, most of which could be eliminated with early screening. Globally these delays cause approximately 300,000 unnecessary deaths per year. We are responding to the opportunity by developing software to automatically analyse routine CT scans to enable early screening for diseases. Lot 1: The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; a. Act for the company in the spin-out legal process and address all company formation matters; b. Provide to the appropriate university all matters necessary for Research England reporting requirements; (3) Finalise market-ready product spec and validate TAM (Total Addressable Market) (4) Engage with angels/VCs to attempt funding and promote to international partners